Genix Pharmaceuticals Corporation
GENPF
$0.01
-$0.02-53.00%
OTC PK
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -38.10K | -66.50K | -60.80K | -36.60K | -75.50K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | 200.00 | 200.00 | 200.00 | 200.00 |
| Total Other Non-Cash Items | 20.40K | 41.50K | 30.80K | 20.90K | 33.60K |
| Change in Net Operating Assets | -4.60K | 2.40K | 18.40K | 5.50K | -2.80K |
| Cash from Operations | -22.30K | -22.40K | -11.40K | -10.00K | -44.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 1.10K | 16.00K | 15.40K | 54.80K |
| Total Debt Repaid | -- | -30.00K | -- | -- | -- |
| Issuance of Common Stock | -- | 100.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1.10K | -- | -- | -- |
| Cash from Financing | -- | 50.40K | 11.70K | 10.80K | 38.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.30K | 28.10K | 200.00 | 800.00 | -5.80K |